David Wilson, MD
Vascular Surgery · Rome, GANPI 1619947017
Payments from drug & device makers
Across 41 payments — averaging $25.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$380
- Angiodynamics, Inc.$193
- Boston Scientific$127
- Medtronic$107
- Lemaitre Vascular, Inc.$89
- Silk Road Medical, Inc.$81
- plus $84 from 5 others
What the payments were for
- Food & beverage$1,062100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 11 | $380 |
| Angiodynamics, Inc. | 7 | $193 |
| Boston Scientific | 7 | $127 |
| Medtronic(2 entities) | 6 | $107 |
| Lemaitre Vascular, Inc. | 1 | $89 |
| Silk Road Medical, Inc. | 4 | $81 |
| Terumo Medical Corporation | 1 | $21 |
| Veryan Medical Incorporated | 1 | $20 |
| Cardinal Health 200 LLC | 1 | $18 |
| Cordis US CORP. | 1 | $14 |
| Bard Peripheral Vascular, Inc. | 1 | $12 |
How this compares
$1,062 in reported general payments places this provider in the 15th percentile of 176 vascular surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 90 | $61,180 |
| BrilintaTicagrelor | 17 | $8,298 |
| XareltoRivaroxaban | 13 | $6,964 |
| ClopidogrelClopidogrel Bisulfate | 189 | $2,083 |
| Atorvastatin Calcium | 43 | $525 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 55 | $286 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 18 | $250 |
| Pentoxifylline | 13 | $189 |
| Cilostazol | 11 | $182 |
| Warfarin Sodium | 11 | $114 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $52 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Rome
- John KirklandRome$14K
- Suman AnnambhotlaGainesville$986K
- Siddharth PatelAtlanta$381K
- Yazan DuwayriAtlanta$284K
- Houman TamaddonAugusta$242K
- William JordanAugusta$211K
- Charles RossAtlanta$178K
- Juan AyerdiColumbus$130K
- Steven OweidaMarietta$114K
- Albert RichardsonThomasville$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.